About SAINTLIFE PHARMACEUTICALS
SAINTLIFE PHARMACEUTICALS is a Healthcare company based in India. Pharmaceutical manufacturing and distribution operations in India. Its Indian entity Saintlife Pharmaceuticals Limited reported revenue of ₹45.01 Cr. SAINTLIFE PHARMACEUTICALS offers products and services including Capsules and Tablets. Its focus areas include Pharmaceuticals, Medicine Manufacturing, Drug Production and Exports and Supplies.
Company details
Saintlife Pharmaceuticals Limited was established in May 2007 and has expanded its operations to cover all states in India, with approximately 250 channel partners added over time. It is recognized as one of the largest companies in terms of SKU holdings and has received quality excellence awards. A manufacturing unit was set up on 60,000 square feet of land, where 50 percent is dedicated to green areas, and construction covers about 80,000 square feet. The company was incorporated in August 2016 and adheres to guidelines from UK-MHRA, EU, WHO, and ISO 9001:2015 standards, ensuring compliance in pharmaceutical production.
- Headquarters India
- SectorsHealthcare
- Email••••••••
- Website saintlifepharmaceuticals.in
- Social X Facebook
- Legal Name Saintlife Pharmaceuticals Limited
- Date of Incorporation 10 Aug, 2016
- Jurisdiction Dehradun, Uttarakhand, India
- Annual Revenue₹45.01 Cr
FY 2025 · +26% YoY
- Net Profit₹30.9 Lakh
FY 2025 · 1% margin
- EBITDA₹2.10 Cr
FY 2025 · 5% margin
Associated legal entities of SAINTLIFE PHARMACEUTICALS
SAINTLIFE PHARMACEUTICALS operates through Saintlife Pharmaceuticals Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Saintlife Pharmaceuticals Limited CIN U24100UR2016PLC007244 | Active | 10 Aug 2016 | Dehradun, Uttarakhand | ₹45.0 Cr | 3 | View details |
Products & Services of SAINTLIFE PHARMACEUTICALS
SAINTLIFE PHARMACEUTICALS offers a comprehensive portfolio of products and services, including Capsules and Tablets.
Capsules are manufactured and supplied by Saintlife Pharmaceuticals Ltd for various medicinal purposes
Tablets are produced by Saintlife Pharmaceuticals Ltd in different types for distribution in the market
Board of directors of Saintlife Pharmaceuticals Limited (SAINTLIFE PHARMACEUTICALS)
Saintlife Pharmaceuticals Limited is the primary company behind SAINTLIFE PHARMACEUTICALS. The board of Saintlife Pharmaceuticals Limited currently have 3 directors; the longest-serving is Sanjay Nandwani, appointed in 2019. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sanjay Nandwani DIN 06999834 | Director | 04 Oct 2019 | 7 yrs 1 mo | Saintlife Pharmaceuticals Limited |
| Sunil Nandwani DIN 06999853 | Director | 04 Oct 2019 | 7 yrs 1 mo | Saintlife Pharmaceuticals Limited |
| Yash Nandwani DIN 09374546 | Director | 25 Oct 2021 | 5 yrs | Saintlife Pharmaceuticals Limited |
Financials of SAINTLIFE PHARMACEUTICALS
Figures of Saintlife Pharmaceuticals Limited, the primary company behind SAINTLIFE PHARMACEUTICALS, for FY 2025. Revenue was ₹45.01 Cr (+26% year on year). Net profit was ₹30.9 Lakh (1% margin). EBITDA was ₹2.10 Cr (5% margin). Revenue has grown at a compounded annual rate of +21% over three years and +24% over five years.
- ₹45.01 CrRevenue · FY 2025 · +26% YoY
- ₹30.9 LakhNet profit · 1% margin
- ₹2.10 CrEBITDA · 5% margin
- ₹23 LakhPaid-up capital
- +21%Revenue CAGR, 3 years
- +24%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Saintlife Pharmaceuticals Limited are on its company page.
Detailed financial statements for SAINTLIFE PHARMACEUTICALS
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about SAINTLIFE PHARMACEUTICALS
SAINTLIFE PHARMACEUTICALS is headquartered in India.
The primary company behind SAINTLIFE PHARMACEUTICALS, Saintlife Pharmaceuticals Limited, reported revenue of ₹45.01 Cr for FY 2025, up 26% year on year.
Saintlife Pharmaceuticals Limited was established in May 2007 and has expanded its operations to cover all states in India, with approximately 250 channel partners added over time. It is recognized as one of the largest companies in terms of SKU holdings and has received quality excellence awards. A manufacturing unit was set up on 60,000 square feet of land, where 50 percent is dedicated to green areas, and construction covers about 80,000 square feet. The company was incorporated in August 2016 and adheres to guidelines from UK-MHRA, EU, WHO, and ISO 9001:2015 standards, ensuring compliance in pharmaceutical production.
SAINTLIFE PHARMACEUTICALS offers Capsules and Tablets.
SAINTLIFE PHARMACEUTICALS operates through Saintlife Pharmaceuticals Limited.
The legal entities of SAINTLIFE PHARMACEUTICALS currently have 3 directors, including Sanjay Nandwani, Sunil Nandwani, Yash Nandwani.